Results 191 to 200 of about 6,578,993 (340)

Pterostilbene in the Management and Treatment of Multiple Myeloma. [PDF]

Curr Issues Mol Biol
Buehrer BS, Grden AR, Johnson E, Patel MY, Raina R.   +4 more
europepmc   +1 more source

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

New England Journal of Medicine, 2016
M. Dimopoulos, A. Oriol, H. Nahi, J. San-Miguel, N. Bahlis, S. Usmani, N. Rabin, R. Orlowski, M. Komarnicki, Kenshi Suzuki, T. Plesner, S. Yoon, D. Ben Yehuda, P. Richardson, H. Goldschmidt, D. Reece, S. Lisby, N. Khokhar, L. O’Rourke, Christopher Chiu, X. Qin, Mary E. Guckert, T. Ahmadi, P. Moreau   +23 more
semanticscholar   +1 more source

A Case Report of a Special Type of Multiple Myeloma: Kappa Light Chain‐Only

Organ Medicine, EarlyView.
This case illustrates the clinical course of a patient diagnosed with kappa light chain‐only multiple myeloma, a rare subtype of multiple myeloma. Of note, light chain multiple myeloma is characterized by rapid disease progression and severe target organ damage.
Yanhua Dai, Yuanyue Guan, Shiwei Cui, Yuan Gao, Zhipeng Zhao, Rui Li, Li Song, Xiuying Zhao, Runqing Li   +8 more
wiley   +1 more source

Testicular Plasmacytoma as the First Manifestation of Systemic Multiple Myeloma. [PDF]

Diagnostics (Basel)
Rodriguez-Parras P, Zambudio-Munuera A, Herraez-Marcos M, Gutierrez-Tejero F, Arrabal-Polo MA.   +4 more
europepmc   +1 more source

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue, Zachary Nash, Vikram Talaulikar, Shibani Nicum   +3 more
wiley   +1 more source

Multiple myeloma

HemaSphere, 2019
openaire   +5 more sources

Toward a cure for multiple myeloma within a decade. [PDF]

Blood Cancer J
Mohty M, Malard F, Facon T, Harousseau JL.   +3 more
europepmc   +1 more source

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan, Angela Hwang, Nicole Wong Doo, Tracy King, Christian Bryant, Jennifer Zhang, Kristina Whelan, Parisa Fani‐Molky, Giselle Kidson‐Gerber, Annmarie Bosco, Nada Hamad, Gurdeep Parmar, Fiona Kwok, Sam Lai, Silvia Ling, P. Joy Ho, Georgia McCaughan, Adam Bryant   +17 more
wiley   +1 more source

Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial. [PDF]

J Patient Rep Outcomes
Mina R, Mylin AK, Yokoyama H, Magen H, Alsdorf W, Shune L, Isufi I, Harrison SJ, Shah UA, De Champlain A, Katz EG, Gries KS, Schecter JM, Lendvai N, Slaughter A, Lonardi C, Deraedt W, Costa Filho O, Patel N, Florendo E, Ho KF, Karlin L, Weisel K.   +22 more
europepmc   +1 more source

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Leukemia, 2019
Ujjawal H. Gandhi, R. Cornell, A. Lakshman, Zhubin J. Gahvari, Elizabeth McGehee, M. Jagosky, Ridhi Gupta, W. Varnado, M. Fiala, S. Chhabra, E. Malek, J. Mansour, B. Paul, Alyssa Barnstead, Saranya Kodali, A. Neppalli, M. Liedtke, S. Narayana, K. Godby, Yubin Kang, A. Kansagra, Elvira Umyarova, E. Scott, P. Hari, R. Vij, S. Usmani, N. Callander, Shaji K. Kumar, L. Costa   +28 more
semanticscholar   +1 more source